ArticleFrontiers in immunology2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
Open access · goldAbstract readComparative Study
In one paragraph
Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 33 citations in OpenAlex.
- Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisTrial
- Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.Journal of neuro-oncology · 2025Article
- Review
- SARS-CoV-2 memory response in non-hospitalised cases: immunology in the context of a population-based cohort study.Wellcome open research · 2024Article
- Serum antibody fingerprinting of SARS-CoV-2 variants in infected and vaccinated subjects by label-free microarray biosensor.Frontiers in immunology · 2024Article
- Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies.The journal of allergy and clinical immunology. Global · 2023Article
- The changing health impact of vaccines in the COVID-19 pandemic: A modeling study.Cell reports · 2023Article
- Quantification of Severe Acute Respiratory Syndrome Coronavirus 2 Binding Antibody Levels To Assess Infection and Vaccine-Induced Immunity Using WHO Standards.Microbiology spectrum · 2023Article
- Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile.Frontiers in public health · 2023Article
- Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapidFrontiers in immunology · 2023Article
- Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing.Frontiers in immunology · 2023Article
- Article
- Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients: A Prospective Observational Study.Journal of inflammation research · 2023Article
- Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.The Journal of infection · 2022Article
- Human seasonal coronavirus neutralization and COVID-19 severity.Journal of medical virology · 2022Article
- Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19.Journal of clinical virology plus · 2022Article
- Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients.Communications biology · 2022Article
- Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19.Viral immunology · 2022Article
- Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material.Journal of virological methods · 2022Article
- SARS-CoV-2 immunity and vaccine strategies in people with HIV.Oxford open immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 9 institutions in 2 countries.
Javier Castillo-OlivaresLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
David A WellsLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Matteo FerrariLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Andrew C Y ChanLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Peter SmithLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Angalee NadesalingamLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Minna PaloniemiLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
George W CarnellLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Luis OhlendorfLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Diego CantoniViral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham, United Kingdom.
Martin Mayora-NetoViral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham, United Kingdom.
Phil PalmerLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Paul TonksLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Nigel J TempertonViral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham, United Kingdom.
David PeterhoffInstitute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Patrick NeckermannInstitute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Ralf WagnerInstitute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Rainer DoffingerDepartment of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, United Kingdom.
Sarah KempsterDivision of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
Ashley D OtterUK Health Security Agency, Porton Down, United Kingdom.
Amanda SemperUK Health Security Agency, Porton Down, United Kingdom.
Tim BrooksUK Health Security Agency, Porton Down, United Kingdom.
Anna AlbeckaMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
Leo C JamesMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
Mark PageDivision of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
Wilhelm SchwaebleComplement Laboratory, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Helen BaxendaleRoyal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Jonathan L HeeneyLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GBMedway School of Pharmacy · GBUK Health Security AgencyInstitute of Medical Microbiology and Hygiene · DEMRC Laboratory of Molecular Biology · GBNational Institute for Biological Standards and Control · GBAddenbrooke's Hospital · GBPapworth Hospital NHS Foundation Trust · GBUniversity of Regensburg · DE
Funding
Medical Research Council MC_PC_20016Medical Research Council MC_U105181010Wellcome Trust 200594/Z/16/Z
Abstract
Precision monitoring of antibody responses during the COVID-19 pandemic is increasingly important during large scale vaccine rollout and rise in prevalence of
Indexed as
ConvalescenceImmunity, HumoralAntibodies, NeutralizingAntibodies, ViralAntigens, ViralBiomarkersCalibrationCOVID-19COVID-19 Serological TestingHumansImmunoglobulin IsotypesReference StandardsSARS-CoV-2Severity of Illness IndexAntibodies, NeutralizingAntibodies, ViralAntigens, ViralBiomarkersImmunoglobulin IsotypesAntibodiesCorrelates of ProtectionCOVID-19COVID-19 immune responseSARS-CoV-2Serological biomarkersWHO International Standard
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.